Semaglutide and tirzepatide recommended as first-line treatment of obesity and most of its complications in new guidance from European Association for the Study of Obesity (EASO) Semaglutide and tirzepatide recommended as first-line treatment of obesity and most of its complications in new guidance from European Association for the Study of Obesity (EASO) Research
Framework for the pharmacological treatment of obesity and its complications from the European Association for the Study of Obesity Framework for the pharmacological treatment of obesity and its complications from the European Association for the Study of Obesity Policy, Research
Watch interview with ECO Local Hosting President – Luca Busetto Watch interview with ECO Local Hosting President – Luca Busetto ECO
Is coming off semaglutide slowly the key to preventing weight regain? Is coming off semaglutide slowly the key to preventing weight regain? ECO
Watch – Borja Martinez Tellez discuss winning the EASO – NN Foundation Award for Clinical Research Watch – Borja Martinez Tellez discuss winning the EASO – NN Foundation Award for Clinical Research Awards, Early Career Network, ECO
Asking adults living with obesity about their childhood weight could help determine mortality risk Asking adults living with obesity about their childhood weight could help determine mortality risk ECO
Junk food marketing on videogame livestreaming platforms like Twitch increases purchases and consumption among teens Junk food marketing on videogame livestreaming platforms like Twitch increases purchases and consumption among teens ECO
